Lukas Biomedical Inc. (TPEX:6814)
Taiwan · Delayed Price · Currency is TWD 31.00
-0.30 (-0.96%)
Jan 22, 2026, 10:51 AM CST
Lukas Biomedical Market Cap
Lukas Biomedical has a market cap or net worth of 1.31 billion as of January 21, 2026. Its market cap has increased by 3.99% in one year.
Market Cap
1.31B
Enterprise Value
1.41B
Revenue
180.32M
Ranking
n/a
PE Ratio
n/a
Stock Price
31.00
Market Cap Chart
Since December 31, 2020, Lukas Biomedical's market cap has decreased from 1.78B to 1.31B, a decrease of -26.17%. That is a compound annual growth rate of -5.82%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Jan 20, 2026 | 1.30B | - |
| Dec 31, 2025 | 1.30B | 3.85% |
| Dec 31, 2024 | 1.25B | 15.69% |
| Dec 29, 2023 | 1.08B | -6.98% |
| Dec 30, 2022 | 1.16B | -15.47% |
| Dec 30, 2021 | 1.37B | -22.59% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| NeoCore Technology | 1.58B |
| Advagene Biopharma | 1.56B |
| GenMont Biotech Incorporation | 1.55B |
| Enimmune corporation | 1.48B |
| Abnova (Taiwan) | 1.47B |
| Meribank Biotech | 1.35B |
| GeneReach Biotechnology | 1.24B |
| Taiwan Advance Bio-Pharmaceutical | 1.07B |